Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News BioCryst Pharmaceuticals Inc BCRX

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of... see more

Recent & Breaking News (NDAQ:BCRX)

Leading Health Care Stock for Small-Cap Stars is Insys Therapeutics Inc (INSY) for August 15

Equities.com August 15, 2014

BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases

GlobeNewswire August 13, 2014

Leading Health Care Stock for Small-Cap Stars is Raptor Pharmaceutical Corp. (RPTP) for August 8

Equities.com August 8, 2014

Leading Small-Cap Stars Health Care Stock for August 8 Morning Session is Raptor Pharmaceutical Corp. (RPTP)

Equities.com August 8, 2014

BioCryst Reports Second Quarter 2014 Financial Results

GlobeNewswire August 5, 2014

Leading Small-Cap Stars Health Care Stock for August 4 Morning Session is ERBA Diagnostics (ERB)

Equities.com August 4, 2014

BioCryst to Announce Second Quarter 2014 Financial Results August 5

GlobeNewswire July 22, 2014

Can Colombia's New President Revive the Country's Mining Industry?

Equities.com June 10, 2014

BioCryst Announces Exercise of Over-Allotment Option and Completion of Public Offering

GlobeNewswire June 3, 2014

BioCryst to Present at Two Upcoming Investor Conferences

GlobeNewswire June 2, 2014

BioCryst Pharmaceuticals Prices Public Offering of Common Stock

GlobeNewswire May 28, 2014

BioCryst Commences Public Offering of Common Stock

GlobeNewswire May 27, 2014

BioCryst Announces Positive Results From OPuS-1, a Phase 2 Trial of BCX4161 for the Prophylactic Treatment of Hereditary Angioedema

GlobeNewswire May 27, 2014

BioCryst to Announce Results From the BCX4161 OPuS-1 Phase 2 Trial for Hereditary Angioedema May 27

GlobeNewswire May 24, 2014

Iconic Mouse: The Best Investment I Ever Made

Equities.com May 22, 2014

BioCryst to Present at Bank of America Merrill Lynch 2014 Healthcare Conference

GlobeNewswire May 9, 2014

BioCryst Reports First Quarter 2014 Financial Results

GlobeNewswire May 8, 2014

BioCryst to Announce First Quarter 2014 Financial Results May 8

GlobeNewswire April 28, 2014

BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection

GlobeNewswire March 3, 2014

BioCryst Presents BCX4161 Phase 1 Trial and Kallikrein Inhibition Assay Results

GlobeNewswire March 1, 2014